Kanzhun Limited (BZ)

The investment case for Kanzhun is a study in contrasts between a fundamentally resilient business and a stock trapped by its own history. Fundamentally, the company is a high-quality compounder with a fortress balance sheet, generating massive free cash flow and boasting an ROE of 18%. The recent annual performance was a spectacular 61% rebound, erasing previous losses and proving the business can recover from distress. However, the long-term rating is capped because the market has punished this stock relentlessly for three consecutive years prior to this recovery; the cumulative decline of nearly 29% over the last four years creates a significant overhang that investors are slow to forget. The current price is cheap relative to intrinsic value, trading at less than one dollar of sales, but the path to a full multiple expansion remains blocked by this recent trauma. Short-term, the outlook is neutral. The stock is hovering near its 50-day moving average, showing signs of stabilization but lacking the explosive momentum required for a breakout. The statistical forecast models offer almost no guidance, predicting a negligible drift with low confidence, which aligns with the choppy price action seen recently. Options activity confirms this hesitation; while there is some call buying, it is overshadowed by defensive put placement, suggesting traders are hedging against further volatility rather than betting on an immediate surge. Until the price decisively clears the psychological resistance of $16-$17 and the broader sector sentiment improves, the stock will likely remain a hold for income seekers and a wait-and-see proposition for growth investors.